|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee Stock Options (right to buy) | $ 2.45 | 06/28/2021 | M | 38,541 | (10) | 11/13/2027 | Common Stock | 38,541 | $ 0 | 0 | D | ||||
Employee Stock Options (right to buy) | $ 2.45 | 06/28/2021 | M | 10,908 | (10) | 12/01/2027 | Common Stock | 10,908 | $ 0 | 0 | D | ||||
Employee Stock Options (right to buy) | $ 2.45 | 06/28/2021 | M | 20,451 | (10) | 11/13/2028 | Common Stock | 20,451 | $ 0 | 0 | D | ||||
Employee Stock Options (right to buy) | $ 3.48 | 06/28/2021 | M | 100 | (10) | 03/31/2029 | Common Stock | 100 | $ 0 | 63,526 | D | ||||
Employee Stock Options (right to buy) | $ 3.48 | 06/29/2021 | M | 63,526 | (10) | 03/31/2029 | Common Stock | 63,526 | $ 0 | 0 | D | ||||
Employee Stock Options (right to buy) | $ 4.03 | 06/29/2021 | M | 6,474 | (10) | 11/13/2029 | Common Stock | 6,474 | $ 0 | 13,977 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Keller Rodney C. Jr. 900 E. OLD SETTLERS BOULEVARD, SUITE 100 ROUND ROCK, TX 78664 |
X | Chief Executive Officer |
/s/ Rodney C. Keller, Jr. | 06/30/2021 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Represents a broker-assisted sale of shares pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021. |
(2) | These shares were purchased in multiple transactions at a price of $5.00. |
(3) | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.00 to $5.019, inclusive. The reporting person undertakes to provide to AYRO, Inc., any security holder of AYRO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
(4) | Represents an exercise of an option to purchase 38,541 shares. The price reported in Column 4 is the exercise price of the underlying options assigned upon grant. |
(5) | Represents an exercise of an option to purchase 100 shares. The price reported in Column 4 is the exercise price of the underlying options assigned upon grant. |
(6) | Represents an exercise of an option to purchase 10,908 shares. The price reported in Column 4 is the exercise price of the underlying options assigned upon grant. |
(7) | Represents an exercise of an option to purchase 20,451 shares. The price reported in Column 4 is the exercise price of the underlying options assigned upon grant. |
(8) | Represents an exercise of an option to purchase 63,526 shares. The price reported in Column 4 is the exercise price of the underlying options assigned upon grant. |
(9) | Represents an exercise of an option to purchase 6,474 shares. The price reported in Column 4 is the exercise price of the underlying options assigned upon grant. |
(10) | These options are fully vested and exercisable. |